Tumorigenicity Assays

Abstract

Tumorigenicity is defined as the ability of cultured cells to give rise to either benign or malignant progressively growing tumours showing viable and mitotically active cells in immunologically nonresponsive animals over a limited observation period. The ability of a cell line to produce tumour in an animal is highly dependent on and defined by the assay in which it is tested. A variety of animal systems are suitable for in vivo tumorigenesis studies.

Keywords: tumorigenicity; invasion; mice; tumour cell culture

References

Bosma GC, Custer RP and Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301: 527–530.

Capecchi MR (1988) Altering the genome by homologous recombination. Science 244: 1288–1292.

Furesz J, Fanok A, Contreras G and Becker B (1989) Tumorigenicity testing of various cell substrates for production of biologicals. Developments in Biological Standardization 70: 233–243.

Gurtsevitch VE and Lenoir GM (1985) Tumorigenic potential of various Burkitt's lymphoma cell lines in nude mice. In: Rygaard J, Brünner N, Graem N and Spang‐Thomsen M (eds) Immune‐Deficient Animals in Biomedical Research, pp. 199–203. Basel: Kargel.

Levenbrook IS, Petricciani JC, Qi Y et al. (1985) Tumorigenicity testing of primate cell lines in nude mice, muscle organ culture and for colony formation in soft agarose. Journal of Biological Standardization 13: 135–141.

Rygaard J (1973) Thymus and Self: Immunobiology of the Mouse Mutant Nude. London: Wiley.

Shinkai Y, Rathbun G, Lam KP et al. (1992) RAG‐2‐deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68(5): 855–867.

Steel GG, Courtenay VD and Rostom AY (1978) Improved immune‐suppression techniques for the exongrafting of human tumours. British Journal of Cancer 37: 224–230.

Talmadge JE, Meyers KM, Prieur DJ and Starkey JR (1980) Role of NK cells in tumour growth and metastasis in beige mice. Nature 284(5757): 622–624.

World Health Organization (WHO) (1987) Requirements for Continuous Cell Lines Used for Biologicals Production. WHO Technical Report Series, No. 745, Annex 3. Geneva: WHO.

World Health Organization (WHO) (1998) Requirements for Continuous‐Cell‐Line Substrates. WHO Technical Report Series, No. 878, Annex 1, Part B. Geneva: WHO.

Xie X, Brünner N, Jensen G et al. (1992) Comparative studies between nude and scid mice on the growth and metastatic behavior of xenografted human tremors. Clinical and Experimental Metastasis 10: 201–210.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Frandsen, Thomas Leth, Holst‐Hansen, Claus, and Brünner, Nils(Apr 2001) Tumorigenicity Assays. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1038/npg.els.0002608]